DG
EW icon

DMC Group’s Edwards Lifesciences EW Stock Holding History

DMC Group’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-4,349
Closed -$402K – 134
2024
Q2 		$402K Sell
4,349
-398
-8% -$35.2K 0.34% 85
2024
Q1 		$454K Buy
4,747
+1,186
+33% +$99.6K 0.39% 82
2023
Q4 		$272K Buy
3,561
+154
+5% +$10.7K 0.26% 105
2023
Q3 		$236K Sell
3,407
-85
-2% -$6.83K 0.22% 105
2023
Q2 		$329K Sell
3,492
-17
-0.5% -$1.48K 0.33% 90
2023
Q1 		$288K Buy
3,509
+746
+27% +$58.6K 0.29% 99
2022
Q4 		$205K Sell
2,763
-35
-1% -$2.7K 0.23% 110
2022
Q3 		$239K Buy
2,798
+178
+7% +$17.1K 0.29% 93
2022
Q2 		$253K Buy
2,620
+41
+2% +$4.24K 0.3% 89
2022
Q1 		$305K Sell
2,579
-1,957
-43% -$220K 0.34% 81
2021
Q4 		$462K Buy
+4,536
New +$529K 0.4% 74

Other funds holding EW

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

DMC Group's EW Position: Q3 2024 in Review

DMC Group sold out of Edwards Lifesciences (EW) in Q3 2024, closing a stake of 4,349 shares — an estimated $402K sold.

DMC Group first reported a position in EW in Q4 2021 and held it in 11 quarters. The position peaked at $462K in Q4 2021. 1,194 funds tracked by Wall St. Rank hold EW as of Q3 2024.

  • DMC Group reported no remaining Edwards Lifesciences position as of Q3 2024 after selling out during the quarter.
  • DMC Group sold 4,349 Edwards Lifesciences shares in Q3 2024, an estimated $402K.
  • DMC Group first reported a position in Edwards Lifesciences in Q4 2021 and held it in 11 quarters.
  • DMC Group's Edwards Lifesciences position peaked at $462K in Q4 2021.
  • 1,194 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2024.

Based on DMC Group's 13F filing for Q3 2024, filed 18 Oct 2024.